ArticleScientific reports2023

Thrombospondin1 antagonist peptide treatment attenuates obesity-associated chronic inflammation and metabolic disorders in a diet-induced obese mouse model.

Qi Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.